Palliative systemic chemotherapy with or without pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin (PIPAC C/D) for gastric cancer with peritoneal metastasis: A propensity score analysis.

Vladimir Khomiakov,Christoph Meisner,A. B. Ryabov,Larisa Bolotina,A. B. Utkina,Ilia Kolobaev,D. D. Sobolev,A. Chayka

Palliative systemic chemotherapy with or without pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin (PIPAC C/D) for gastric cancer with peritoneal metastasis: A propensity score analysis.

2020

Vladimir Khomiakov
Christoph Meisner
A. B. Ryabov
Larisa Bolotina
A. B. Utkina
Ilia Kolobaev
D. D. Sobolev
A. Chayka

380Background: Gastric cancer (GC) with peritoneal metastasis (PM) has a dismal prognosis. Palliative systemic chemotherapy (SC), usually doublet combinations of platinum and fluoropyrimidines, is ...

Keywords:

Doxorubicin
Cancer
Metastasis
Internal medicine
Propensity score matching
Cisplatin
Chemotherapy
Medicine
Oncology
Pathology
peritoneal metastasis
systemic chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations